Fundamental analysis by سیگنال و تحلیل سهام | بورسکده | about Stock دسینا on 7/19/2025

# #Degree #Degree Production Contents: Company production and sales are in line with forecast budget and have not been significantly different from previous years. ⚙️ Sales Rate: Injecting prices in injectable drugs in year 2 due to rising cost of production, rising exchange rates, lack of some items and their production loss for companies were about 100 %. Product sales were considered in accordance with the latest sales rates without rising prices. ⚙️ The cost of a 65 % share of the cost of the participation. The company receives 60 % of its currency and the other dollar -related materials are agreed. The $ 75,000 dollar rate for the company. In this analysis, production costs are estimated at about 2 %. Sina Drug's confidence, given the permission to raise the rate this year, was still profitable and, given the anticipated profit, has an attractive price -to -profit ratio like other industry companies in this sector. 🧡 Value investment